Pentadecapeptide BPC 157 counteracts portal hypertension, caval hypertension and aortal hypotension with suprahepatic occlusion of inferior caval vein in rats

Portal hypertension, aortal hypotension, caval hypertension

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Liječnički vjesnik 2019, Vol.141 (suppl.1)
Hauptverfasser:	Gojković, Slaven, Vraneš, Hrvoje, Jelovečki – Dokić, Zoya, Marcel Koltay, Oliver, Migo, Will, Malekinušić, Dominik
Format:	Web Resource
Sprache:	eng
Schlagworte:	and arterial hypotension and most importantly and thereby as an abdominal bath or as an intragastric application at 24 h or 48 h of ligation time. Medication (BPC 157) at 24 h or 48 h reperfusion time. Assessment of portal caval and aortal pressure showed huge portal hypertension and more caval hypertension along with mild aortic hypotension. Contrarily counteracts portal hypertension and caval hypotension. In deeply anesthetized and laparatomized rats that have suprahepatic occlusion of ICV even elevated in comparison to portal hypertension in rats with portal triad obstruction BPC 157 beneficially increased vessels branching in the intestinal serosa and counteracted intestinal lesions. It also counteracts free radical formation inferior caval vein and abdominal aorta at the level of bifurcation inserted into the portal vein may be a consistent therapy solution or saline (controls)) was applied in rats with suprahepatic occlusion of ICV spontaneous decompression of the portal system can hardly be expected by a portocaval shunt. BPC 157 suprahepatic ICV occlusion provides high caval hypertension the recording lasted 5 minutes with a cannula (assessed in one minute intervals) connected to a pressure transducer these disturbances were marked counteracted. Thus We introduce pentadecapeptide BPC 157 as the therapy of the hemodynamic disturbances in the prolonged suprahepatic occlusion of inferior caval vein (ICV) in rats mimicking Budd-Chiari syndrome. Previously when BPC 157 was given in those circumstances of the portal and caval hypertension
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue	suppl.1
container_start_page
container_title	Liječnički vjesnik
container_volume	141
creator	Gojković, Slaven Vraneš, Hrvoje Jelovečki – Dokić, Zoya Marcel Koltay, Oliver Migo, Will Malekinušić, Dominik
description	Portal hypertension, aortal hypotension, caval hypertension
format	Web Resource
fullrecord	<record><control><sourceid>hrcak</sourceid><recordid>TN_cdi_hrcak_primary_oai_hrcak_srce_hr_224625</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_hrcak_srce_hr_224625</sourcerecordid><originalsourceid>FETCH-hrcak_primary_oai_hrcak_srce_hr_2246253</originalsourceid><addsrcrecordid>eNqVjEFOwzAQRS0EUiPoHeYAjRQ7Lm63rUAsu2AfDc5EGRFsa-wU9TKclQoKC3as_tf7T_9KVXpjt7XRzl2rqmmMrVvr3EItc-aXxuit06a1lfo4UCjYk8dEqXBPsDvsQa8d-DiHQoK-ZEhRCk4wnhJJoZA5hhV4PP5hgKEH_HXjD37nMkKek-BICQt7iN5P89cWB-AwkHCUy-OROJwZCJZ8p24GnDItL3mr6seH5_1TPYrH1y4Jv6GcuojcfZMsns61M8bem3X7X_8TMaVoPw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>web_resource</recordtype></control><display><type>web_resource</type><title>Pentadecapeptide BPC 157 counteracts portal hypertension, caval hypertension and aortal hypotension with suprahepatic occlusion of inferior caval vein in rats</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Gojković, Slaven ; Vraneš, Hrvoje ; Jelovečki – Dokić, Zoya ; Marcel Koltay, Oliver ; Migo, Will ; Malekinušić, Dominik</creator><creatorcontrib>Gojković, Slaven ; Vraneš, Hrvoje ; Jelovečki – Dokić, Zoya ; Marcel Koltay, Oliver ; Migo, Will ; Malekinušić, Dominik</creatorcontrib><description>Portal hypertension, aortal hypotension, caval hypertension</description><identifier>ISSN: 0024-3477</identifier><identifier>EISSN: 1849-2177</identifier><identifier>CODEN: LIVJA5</identifier><language>eng</language><publisher>Hrvatski liječnički zbor</publisher><subject>and arterial hypotension ; and most importantly ; and thereby ; as an abdominal bath or as an intragastric application ; at 24 h or 48 h of ligation time. Medication (BPC 157) ; at 24 h or 48 h reperfusion time. Assessment of portal ; caval and aortal pressure showed huge portal hypertension and more caval hypertension along with mild aortic hypotension. Contrarily ; counteracts portal hypertension and caval hypotension. In deeply anesthetized and laparatomized rats that have suprahepatic occlusion of ICV ; even elevated in comparison to portal hypertension ; in rats with portal triad obstruction BPC 157 beneficially increased vessels branching in the intestinal serosa and counteracted intestinal lesions. It also counteracts free radical formation ; inferior caval vein and abdominal aorta at the level of bifurcation ; inserted into the portal vein ; may be a consistent therapy solution ; or saline (controls)) was applied in rats with suprahepatic occlusion of ICV ; spontaneous decompression of the portal system can hardly be expected by a portocaval shunt. BPC 157 ; suprahepatic ICV occlusion provides high caval hypertension ; the recording lasted 5 minutes with a cannula (assessed in one minute intervals) connected to a pressure transducer ; these disturbances were marked counteracted. Thus ; We introduce pentadecapeptide BPC 157 as the therapy of the hemodynamic disturbances in the prolonged suprahepatic occlusion of inferior caval vein (ICV) in rats mimicking Budd-Chiari syndrome. Previously ; when BPC 157 was given in those circumstances of the portal and caval hypertension</subject><ispartof>Liječnički vjesnik, 2019, Vol.141 (suppl.1)</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttps://hrcak.srce.hr/logo_broj/17693.jpg</thumbnail><link.rule.ids>230,780,784,885</link.rule.ids></links><search><creatorcontrib>Gojković, Slaven</creatorcontrib><creatorcontrib>Vraneš, Hrvoje</creatorcontrib><creatorcontrib>Jelovečki – Dokić, Zoya</creatorcontrib><creatorcontrib>Marcel Koltay, Oliver</creatorcontrib><creatorcontrib>Migo, Will</creatorcontrib><creatorcontrib>Malekinušić, Dominik</creatorcontrib><title>Pentadecapeptide BPC 157 counteracts portal hypertension, caval hypertension and aortal hypotension with suprahepatic occlusion of inferior caval vein in rats</title><title>Liječnički vjesnik</title><description>Portal hypertension, aortal hypotension, caval hypertension</description><subject>and arterial hypotension</subject><subject>and most importantly</subject><subject>and thereby</subject><subject>as an abdominal bath or as an intragastric application</subject><subject>at 24 h or 48 h of ligation time. Medication (BPC 157)</subject><subject>at 24 h or 48 h reperfusion time. Assessment of portal</subject><subject>caval and aortal pressure showed huge portal hypertension and more caval hypertension along with mild aortic hypotension. Contrarily</subject><subject>counteracts portal hypertension and caval hypotension. In deeply anesthetized and laparatomized rats that have suprahepatic occlusion of ICV</subject><subject>even elevated in comparison to portal hypertension</subject><subject>in rats with portal triad obstruction BPC 157 beneficially increased vessels branching in the intestinal serosa and counteracted intestinal lesions. It also counteracts free radical formation</subject><subject>inferior caval vein and abdominal aorta at the level of bifurcation</subject><subject>inserted into the portal vein</subject><subject>may be a consistent therapy solution</subject><subject>or saline (controls)) was applied in rats with suprahepatic occlusion of ICV</subject><subject>spontaneous decompression of the portal system can hardly be expected by a portocaval shunt. BPC 157</subject><subject>suprahepatic ICV occlusion provides high caval hypertension</subject><subject>the recording lasted 5 minutes with a cannula (assessed in one minute intervals) connected to a pressure transducer</subject><subject>these disturbances were marked counteracted. Thus</subject><subject>We introduce pentadecapeptide BPC 157 as the therapy of the hemodynamic disturbances in the prolonged suprahepatic occlusion of inferior caval vein (ICV) in rats mimicking Budd-Chiari syndrome. Previously</subject><subject>when BPC 157 was given in those circumstances of the portal and caval hypertension</subject><issn>0024-3477</issn><issn>1849-2177</issn><fulltext>true</fulltext><rsrctype>web_resource</rsrctype><creationdate>2019</creationdate><recordtype>web_resource</recordtype><recordid>eNqVjEFOwzAQRS0EUiPoHeYAjRQ7Lm63rUAsu2AfDc5EGRFsa-wU9TKclQoKC3as_tf7T_9KVXpjt7XRzl2rqmmMrVvr3EItc-aXxuit06a1lfo4UCjYk8dEqXBPsDvsQa8d-DiHQoK-ZEhRCk4wnhJJoZA5hhV4PP5hgKEH_HXjD37nMkKek-BICQt7iN5P89cWB-AwkHCUy-OROJwZCJZ8p24GnDItL3mr6seH5_1TPYrH1y4Jv6GcuojcfZMsns61M8bem3X7X_8TMaVoPw</recordid><startdate>20190409</startdate><enddate>20190409</enddate><creator>Gojković, Slaven</creator><creator>Vraneš, Hrvoje</creator><creator>Jelovečki – Dokić, Zoya</creator><creator>Marcel Koltay, Oliver</creator><creator>Migo, Will</creator><creator>Malekinušić, Dominik</creator><general>Hrvatski liječnički zbor</general><scope>VP8</scope></search><sort><creationdate>20190409</creationdate><title>Pentadecapeptide BPC 157 counteracts portal hypertension, caval hypertension and aortal hypotension with suprahepatic occlusion of inferior caval vein in rats</title><author>Gojković, Slaven ; Vraneš, Hrvoje ; Jelovečki – Dokić, Zoya ; Marcel Koltay, Oliver ; Migo, Will ; Malekinušić, Dominik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-hrcak_primary_oai_hrcak_srce_hr_2246253</frbrgroupid><rsrctype>web_resources</rsrctype><prefilter>web_resources</prefilter><language>eng</language><creationdate>2019</creationdate><topic>and arterial hypotension</topic><topic>and most importantly</topic><topic>and thereby</topic><topic>as an abdominal bath or as an intragastric application</topic><topic>at 24 h or 48 h of ligation time. Medication (BPC 157)</topic><topic>at 24 h or 48 h reperfusion time. Assessment of portal</topic><topic>caval and aortal pressure showed huge portal hypertension and more caval hypertension along with mild aortic hypotension. Contrarily</topic><topic>counteracts portal hypertension and caval hypotension. In deeply anesthetized and laparatomized rats that have suprahepatic occlusion of ICV</topic><topic>even elevated in comparison to portal hypertension</topic><topic>in rats with portal triad obstruction BPC 157 beneficially increased vessels branching in the intestinal serosa and counteracted intestinal lesions. It also counteracts free radical formation</topic><topic>inferior caval vein and abdominal aorta at the level of bifurcation</topic><topic>inserted into the portal vein</topic><topic>may be a consistent therapy solution</topic><topic>or saline (controls)) was applied in rats with suprahepatic occlusion of ICV</topic><topic>spontaneous decompression of the portal system can hardly be expected by a portocaval shunt. BPC 157</topic><topic>suprahepatic ICV occlusion provides high caval hypertension</topic><topic>the recording lasted 5 minutes with a cannula (assessed in one minute intervals) connected to a pressure transducer</topic><topic>these disturbances were marked counteracted. Thus</topic><topic>We introduce pentadecapeptide BPC 157 as the therapy of the hemodynamic disturbances in the prolonged suprahepatic occlusion of inferior caval vein (ICV) in rats mimicking Budd-Chiari syndrome. Previously</topic><topic>when BPC 157 was given in those circumstances of the portal and caval hypertension</topic><toplevel>online_resources</toplevel><creatorcontrib>Gojković, Slaven</creatorcontrib><creatorcontrib>Vraneš, Hrvoje</creatorcontrib><creatorcontrib>Jelovečki – Dokić, Zoya</creatorcontrib><creatorcontrib>Marcel Koltay, Oliver</creatorcontrib><creatorcontrib>Migo, Will</creatorcontrib><creatorcontrib>Malekinušić, Dominik</creatorcontrib><collection>Hrcak: Portal of scientific journals of Croatia</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gojković, Slaven</au><au>Vraneš, Hrvoje</au><au>Jelovečki – Dokić, Zoya</au><au>Marcel Koltay, Oliver</au><au>Migo, Will</au><au>Malekinušić, Dominik</au><format>book</format><genre>unknown</genre><ristype>GEN</ristype><atitle>Pentadecapeptide BPC 157 counteracts portal hypertension, caval hypertension and aortal hypotension with suprahepatic occlusion of inferior caval vein in rats</atitle><jtitle>Liječnički vjesnik</jtitle><date>2019-04-09</date><risdate>2019</risdate><volume>141</volume><issue>suppl.1</issue><issn>0024-3477</issn><eissn>1849-2177</eissn><coden>LIVJA5</coden><abstract>Portal hypertension, aortal hypotension, caval hypertension</abstract><pub>Hrvatski liječnički zbor</pub><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0024-3477
ispartof	Liječnički vjesnik, 2019, Vol.141 (suppl.1)
issn	0024-3477 1849-2177
language	eng
recordid	cdi_hrcak_primary_oai_hrcak_srce_hr_224625
source	DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects	and arterial hypotension and most importantly and thereby as an abdominal bath or as an intragastric application at 24 h or 48 h of ligation time. Medication (BPC 157) at 24 h or 48 h reperfusion time. Assessment of portal caval and aortal pressure showed huge portal hypertension and more caval hypertension along with mild aortic hypotension. Contrarily counteracts portal hypertension and caval hypotension. In deeply anesthetized and laparatomized rats that have suprahepatic occlusion of ICV even elevated in comparison to portal hypertension in rats with portal triad obstruction BPC 157 beneficially increased vessels branching in the intestinal serosa and counteracted intestinal lesions. It also counteracts free radical formation inferior caval vein and abdominal aorta at the level of bifurcation inserted into the portal vein may be a consistent therapy solution or saline (controls)) was applied in rats with suprahepatic occlusion of ICV spontaneous decompression of the portal system can hardly be expected by a portocaval shunt. BPC 157 suprahepatic ICV occlusion provides high caval hypertension the recording lasted 5 minutes with a cannula (assessed in one minute intervals) connected to a pressure transducer these disturbances were marked counteracted. Thus We introduce pentadecapeptide BPC 157 as the therapy of the hemodynamic disturbances in the prolonged suprahepatic occlusion of inferior caval vein (ICV) in rats mimicking Budd-Chiari syndrome. Previously when BPC 157 was given in those circumstances of the portal and caval hypertension
title	Pentadecapeptide BPC 157 counteracts portal hypertension, caval hypertension and aortal hypotension with suprahepatic occlusion of inferior caval vein in rats
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T23%3A50%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hrcak&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Pentadecapeptide%20BPC%20157%20counteracts%20portal%20hypertension,%20caval%20hypertension%20and%20aortal%20hypotension%20with%20suprahepatic%20occlusion%20of%20inferior%20caval%20vein%20in%20rats&rft.jtitle=Lije%C4%8Dni%C4%8Dki%20vjesnik&rft.au=Gojkovi%C4%87,%20Slaven&rft.date=2019-04-09&rft.volume=141&rft.issue=suppl.1&rft.issn=0024-3477&rft.eissn=1849-2177&rft.coden=LIVJA5&rft_id=info:doi/&rft_dat=%3Chrcak%3Eoai_hrcak_srce_hr_224625%3C/hrcak%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true